Allogene Therapeutics, Inc.
ALLONasdaqCIK 1737287HealthcareFiscal year ends Dec 31
All transactions: 3
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Parker Geoffrey M.CHIEF FINANCIAL OFFICER, Officer | Sale | 36,342 | $1.34 | $48.7k | Form 4 |
| 2018-10-15 | Pfizer Inc10% owner | Purchase | 55,556 | $18.00 | $1.0m | Form 4 |
| 2018-10-15 | Pfizer Inc10% owner | Conversion | 21,976,484 | not reported | not reported | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.